A University of Minnesota research team has developed a new delivery system for a combination of two FDA approved drugs that may serve as an effective treatment for the human immunodeficiency virus. The discovery, which allows for a combination of decitabine and gemcitabine to be delivered in pill form, marks a major step forward in patient feasibility for the drugs, which previously had been available solely via injection or intravenous therapy.
Fuente : http://www.eurekalert.org/pub_releases/2013-08/uom…
Hacer un comentario